Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free BNBX Stock Alerts

Applied Dna Sciences (BNBX) Competitors

Applied Dna Sciences logo
$0.39 -0.01 (-2.50%)
Closing price 03:59 PM Eastern
Extended Trading
$0.40 +0.01 (+2.05%)
As of 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BNBX vs. ZBAI, STFS, SFHG, AWX, and NOTV

Should you buy Applied Dna Sciences stock or one of its competitors? MarketBeat compares Applied Dna Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Applied Dna Sciences include ATIF (ZBAI), Star Fashion Culture (STFS), Samfine Creation Holdings Group (SFHG), Avalon (AWX), and Inotiv (NOTV). These companies are all part of the "business services" industry.

How does Applied Dna Sciences compare to ATIF?

ATIF (NASDAQ:ZBAI) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

22.2% of Applied Dna Sciences shares are owned by institutional investors. 32.2% of ATIF shares are owned by insiders. Comparatively, 6.1% of Applied Dna Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, ATIF's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company Overall Sentiment
ATIF Neutral
Applied Dna Sciences Neutral

ATIF has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. ATIF's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ATIFN/A N/A N/A
Applied Dna Sciences -1,647.25%-349.95%-283.96%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ATIF
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

ATIF has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

ATIF has higher earnings, but lower revenue than Applied Dna Sciences. ATIF is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ATIF$1.20M9.74-$4.60M-$7.19N/A
Applied Dna Sciences$2.09M1.34-$15.16M-$36.76N/A

Summary

ATIF beats Applied Dna Sciences on 7 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to Star Fashion Culture?

Star Fashion Culture (NASDAQ:STFS) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

Star Fashion Culture has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Star Fashion Culture's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Star Fashion CultureN/A N/A N/A
Applied Dna Sciences -1,647.25%-349.95%-283.96%

22.2% of Applied Dna Sciences shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Applied Dna Sciences has lower revenue, but higher earnings than Star Fashion Culture.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Star Fashion Culture$16.86M0.65-$18.26MN/AN/A
Applied Dna Sciences$2.09M1.34-$15.16M-$36.76N/A

Star Fashion Culture has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Star Fashion Culture
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Star Fashion Culture had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for Star Fashion Culture and 0 mentions for Applied Dna Sciences. Star Fashion Culture's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company Overall Sentiment
Star Fashion Culture Neutral
Applied Dna Sciences Neutral

Summary

Star Fashion Culture and Applied Dna Sciences tied by winning 5 of the 10 factors compared between the two stocks.

How does Applied Dna Sciences compare to Samfine Creation Holdings Group?

Samfine Creation Holdings Group (NASDAQ:SFHG) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Samfine Creation Holdings Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Samfine Creation Holdings Group has higher revenue and earnings than Applied Dna Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Samfine Creation Holdings Group$169.79M0.06-$2.55MN/AN/A
Applied Dna Sciences$2.09M1.34-$15.16M-$36.76N/A

In the previous week, Samfine Creation Holdings Group's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company Overall Sentiment
Samfine Creation Holdings Group Neutral
Applied Dna Sciences Neutral

Samfine Creation Holdings Group has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Samfine Creation Holdings Group's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Samfine Creation Holdings GroupN/A N/A N/A
Applied Dna Sciences -1,647.25%-349.95%-283.96%

Samfine Creation Holdings Group has a beta of 2.09, indicating that its share price is 109% more volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

22.2% of Applied Dna Sciences shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Samfine Creation Holdings Group beats Applied Dna Sciences on 6 of the 9 factors compared between the two stocks.

How does Applied Dna Sciences compare to Avalon?

Applied Dna Sciences (NASDAQ:BNBX) and Avalon (NYSE:AWX) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Avalon has higher revenue and earnings than Applied Dna Sciences. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Avalon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Dna Sciences$2.09M1.34-$15.16M-$36.76N/A
Avalon$85.14M0.12-$1.77M$0.1517.07

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 34.4% of Avalon shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 20.0% of Avalon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Avalon's average media sentiment score of 1.65 beat Applied Dna Sciences' score of 0.00 indicating that Avalon is being referred to more favorably in the news media.

Company Overall Sentiment
Applied Dna Sciences Neutral
Avalon Very Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Avalon
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Applied Dna Sciences has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, Avalon has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Avalon has a net margin of 1.17% compared to Applied Dna Sciences' net margin of -1,647.25%. Avalon's return on equity of 2.72% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied Dna Sciences-1,647.25% -349.95% -283.96%
Avalon 1.17%2.72%1.10%

Summary

Avalon beats Applied Dna Sciences on 11 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to Inotiv?

Inotiv (NASDAQ:NOTV) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Inotiv has a beta of 3.82, meaning that its share price is 282% more volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

Inotiv currently has a consensus price target of $1.50, indicating a potential upside of 461.80%. Given Inotiv's stronger consensus rating and higher possible upside, equities analysts plainly believe Inotiv is more favorable than Applied Dna Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inotiv
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Applied Dna Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

18.2% of Inotiv shares are held by institutional investors. Comparatively, 22.2% of Applied Dna Sciences shares are held by institutional investors. 7.8% of Inotiv shares are held by company insiders. Comparatively, 6.1% of Applied Dna Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Inotiv's average media sentiment score of 0.00 equaled Applied Dna Sciences'average media sentiment score.

Company Overall Sentiment
Inotiv Neutral
Applied Dna Sciences Neutral

Applied Dna Sciences has lower revenue, but higher earnings than Inotiv. Inotiv is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inotiv$507.36M0.02-$68.62M-$2.53N/A
Applied Dna Sciences$2.09M1.34-$15.16M-$36.76N/A

Inotiv has a net margin of -17.14% compared to Applied Dna Sciences' net margin of -1,647.25%. Inotiv's return on equity of -56.77% beat Applied Dna Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Inotiv-17.14% -56.77% -8.91%
Applied Dna Sciences -1,647.25%-349.95%-283.96%

Summary

Inotiv beats Applied Dna Sciences on 10 of the 14 factors compared between the two stocks.

Get Applied Dna Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNBX vs. The Competition

Export
MetricApplied Dna SciencesServices – Research, Development, Testing Labs IndustryServices SectorNASDAQ Exchange
Market Cap$2.81M$10.04M$999.46M$12.46B
Dividend YieldN/AN/A5.14%5.27%
P/E Ratio-0.01N/A9.3625.85
Price / Sales1.343.4540.6568.57
Price / CashN/AN/A381.8256.67
Price / Book0.230.234.357.15
Net Income-$15.16M-$15.16M-$13.24M$336.98M
7 Day Performance-4.88%-10.32%1.92%3.36%
1 Month Performance-26.33%-21.31%-4.65%3.52%
1 Year PerformanceN/AN/A52.31%36.41%

Applied Dna Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNBX
Applied Dna Sciences
0.7832 of 5 stars		$0.39
-2.5%		N/AN/A$2.81M$2.09MN/A70
ZBAI
ATIF
0.2277 of 5 stars		$8.86
-1.1%		N/A-45.4%$11.69M$1.20MN/A10
STFS
Star Fashion Culture
0.6416 of 5 stars		$9.46
+26.0%		N/A-80.6%$11.26M$16.86MN/A22
SFHG
Samfine Creation Holdings Group
0.4701 of 5 stars		$2.54
+1.6%		N/A-44.9%$10.31M$169.79MN/AN/A
AWX
Avalon
N/A$2.54
-0.4%		N/A+5.2%$9.90M$85.14M10.16610

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BNBX) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel